the CD28, 4–1BB, and CD3z moieties, in tandem with the scFv derived from
the human monoclonal antibody 139 and the marker Thy1.1 (38 (link)). CAR T cells were prepared according to previously
reported protocols (50 ). Briefly,
splenocytes that were isolated from donor C57BL/6 mice were made into a
single-cell suspension and cultured in RPMI (HyClone) supplemented with 10% FBS,
50 μM 2-mercaptoethanol (Sigma-Aldrich), 1% PenStrep (Corning), 1%
Non-essential amino acids (NEAA) (Corning), 1% sodium pyruvate (Corning), human
interleukin-2 (IL-2; 50 U/ml; Novartis), and concanavalin A (2.5 ug/ml;
Sigma-Aldrich). In some experiments, CAR T cells were expanded using murine
IL-21 (30 ng/ml), IL-15 (5 ng/ml), and IL-7 (10 ng/ml). Retroviral supernatant
was produced from 293T cells cotransfected with the MSGV1 retroviral plasmid and
the helper plasmid pCL Eco (Imgenex), and T cells were transduced on
RetroNectin-coated plates (Takara) 2 days after stimulation. Cells were split 1
day after transduction and used for in vitro analysis or in vivo administration
on day 4 or 5. Transduced cells were identified by the expression of Thy1.1.